SCWorx Corp. Reports Revenue Growth and Improved Net Loss in Q2 2026

SCWorx Corp. reported its financial results for the second quarter of 2026, revealing a revenue of $706,049 for the three months ending June 30, 2026, which represents a slight increase from $682,632 in the same period of 2025. For the first half of 2026, the company generated $1,450,948 in revenue, up from $1,402,931 in the prior year. Despite this growth in revenue, SCWorx recorded a net loss of $120,954 for the second quarter, a significant improvement compared to a net loss of $1,906,085 in the same quarter of 2025. The loss for the first half of 2026 also decreased to $294,721 from $2,382,388 in the previous year.

The company’s cost of revenue decreased notably, falling to $375,626 in the second quarter of 2026 from $502,215 in the same quarter of 2025. This reduction contributed to a gross profit of $330,423 for the second quarter, compared to $180,417 in the prior year. Operating expenses, however, remained substantial, totaling $451,377 for the second quarter of 2026, down from $473,944 in the same period of 2025. The decrease in operating expenses was primarily attributed to lower legal and professional fees, as well as a reduction in salaries and wages.

In terms of strategic developments, SCWorx implemented a 1-for-12 reverse stock split effective August 4, 2026, following stockholder approval. This move is part of the company's efforts to enhance its stock price and attract a broader range of investors. The company continues to focus on its core business of providing data content and services for healthcare providers, emphasizing interoperability and data normalization. SCWorx's software solutions are marketed primarily through direct sales and partnerships, with clients spread across the United States.

Operationally, SCWorx reported a total of 89,269 shares of common stock outstanding as of June 30, 2026, an increase from 88,310 shares at the end of 2025. The company’s cash position decreased to $1,263,478 from $1,644,439 at the end of the previous fiscal year, reflecting ongoing investments in intangible assets and operational expenses. The company’s total assets also declined to $7,707,901 from $7,896,088, while total liabilities remained stable at $775,632.

Looking ahead, SCWorx management expressed cautious optimism regarding future performance, emphasizing the need to reverse the recent decline in revenue and improve profitability. The company is focused on securing additional financing and reducing its dependence on third-party subcontractors. However, management acknowledged the inherent risks and uncertainties that could impact future results, including market conditions and regulatory changes. The company remains committed to enhancing its product offerings and expanding its market presence in the healthcare technology sector.